Polish Pharmaceuticals & Biotech Potentially Undervalued Companies

Selvita

Market Cap: zł607.6m

Operates as a contract research organization worldwide.

Bayer

Market Cap: zł27.6b

Operates as a life science company worldwide.

Read-Gene

Market Cap: zł67.4m

Engages in the detection, prevention, and treatment of various types of cancer.

Genomed Spólka Akcyjna

Market Cap: zł34.1m

Provides DNA sequencing and analysis, and diagnostics of congenital diseases in Poland.

Novo Nordisk

Market Cap: zł1.5t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

Sopharma AD

Market Cap: zł1.2b

Produces, distributes, and exports pharmaceutical products in Europe, Bulgaria, and internationally.

Stem Cells Spin

Market Cap: zł14.9m

Operates as a biotechnology company in Poland.

Ryvu Therapeutics

Market Cap: zł693.6m

A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.

Krka d. d

Market Cap: zł6.1b

A generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally.

Celon Pharma

Market Cap: zł1.2b

An integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations.